Carey Macrury
Stock Analyst at Canaccord Genuity
(1.32)
# 3,258
Out of 4,748 analysts
17
Total ratings
46.15%
Success rate
-3.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Carey Macrury
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IAG IAMGOLD | Upgrades: Buy | $7.75 → $11 | $6.00 | +75.00% | 2 | Oct 22, 2024 | |
| APTO Aptose Biosciences | Maintains: Buy | $195 → $120 | $0.17 | +69,384.66% | 1 | Mar 27, 2023 | |
| NEM Newmont | Upgrades: Buy | $53 → $55 | $41.59 | +32.24% | 6 | Mar 14, 2023 | |
| RGLD Royal Gold | Upgrades: Buy | $151 → $140 | $137.46 | +1.85% | 2 | Jun 13, 2022 | |
| CGAU Centerra Gold | Downgrades: Speculative Buy | $18 → $15 | $6.09 | +138.10% | 1 | Apr 21, 2021 | |
| AEM Agnico Eagle Mines | Maintains: Buy | $115 → $110 | $90.11 | +22.07% | 5 | Feb 23, 2021 |
IAMGOLD
Oct 22, 2024
Upgrades: Buy
Price Target: $7.75 → $11
Current: $6.00
Upside: +75.00%
Aptose Biosciences
Mar 27, 2023
Maintains: Buy
Price Target: $195 → $120
Current: $0.17
Upside: +69,384.66%
Newmont
Mar 14, 2023
Upgrades: Buy
Price Target: $53 → $55
Current: $41.59
Upside: +32.24%
Royal Gold
Jun 13, 2022
Upgrades: Buy
Price Target: $151 → $140
Current: $137.46
Upside: +1.85%
Centerra Gold
Apr 21, 2021
Downgrades: Speculative Buy
Price Target: $18 → $15
Current: $6.09
Upside: +138.10%
Agnico Eagle Mines
Feb 23, 2021
Maintains: Buy
Price Target: $115 → $110
Current: $90.11
Upside: +22.07%